MyAverix Finance
US · Healthcare
Corbus Pharmaceuticals Holding (CRBP)
Biotechnology
Corbus Pharmaceuticals Holding (CRBP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CRBP
Corbus Pharmaceuticals Holding (CRBP) — FAQ
What is CRBP's P/E ratio?
The price-to-earnings (P/E) ratio for Corbus Pharmaceuticals Holding (CRBP) is 18.00 (data as of 2026-03-24).
Does Corbus Pharmaceuticals Holding pay a dividend?
Dividend yield is not available in the current snapshot for Corbus Pharmaceuticals Holding (CRBP). Check the MyAverix Finance app for the latest dividend data.
What sector is Corbus Pharmaceuticals Holding in?
Corbus Pharmaceuticals Holding (CRBP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CRBP listed on?
CRBP is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.